Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 13, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • corona

Tag: corona

  • BiotechToday
  • World

GWAS identifies more SARS-CoV-2 variants

BioTech Today June 30, 2021June 29, 2021

Souradip Mallick, National Institute of Technology, Rourkela The SARS-CoV-2 virus has mutated very frequently over time that resulted in genetic variation of circulating viral strains throughout the COVID-19 pandemic. Viral mutations can enhance virulence as well as transmissibility in humans. It affects the antigen and serology tests due to the inherent design differences of each […]

Read More
  • BiotechToday
  • World

Artificial Intelligence (AI) for efficient COVID Testing

BioTech Today June 23, 2021June 22, 2021 7

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University For the past one and a half years, we have been struggling with COVID19. The deadly pandemic has taken millions of lives all over the world. Meanwhile, the huge demand has deaccelerated the vaccine rollout. The plan to deal with COVID19 includes extensive testing, contact tracing, quarantining, […]

Read More
  • BiotechToday
  • World

The curious case of Covid-19 Re-infection

bioxone June 22, 2021June 21, 2021 2

Madhavi Bhatia, NIPER Guwahati Coronavirus infection recovery provides a significant amount of immunity to individuals but there are some cases that have revealed that even after successfully recovering from COVID-19 infection there are chances of re-infection. This is mainly found to be due to mutation in the virus leading to different variants like alpha and […]

Read More
  • BiotechToday
  • World

Happy hypoxia: The COVID-19 condition that’s baffling medical professionals

bioxone May 21, 2021May 20, 2021 1

Sampriti Roy, University of Calcutta As the second wave progresses, we are increasingly seeing new and “unpredictable” symptoms associated with the coronavirus. One among those conditions that have silently been causing serious damage is the condition called “Happy Hypoxia”. What is Happy Hypoxia? It is a condition associated with COVID-19 that “seems to defy basic […]

Read More
  • BiotechToday
  • India

DRDO’s “2-DG” Anti-Covid Drug has been finally launched

bioxone May 18, 2021May 18, 2021 5

Anuska Sen, Team BioXone Abbreviations used in the following article: 2-DG: 2-deoxy-D-glucose DRDO: Defence Research and Development Organization INMAS: Institute of Nuclear Medicine and Allied Sciences DCGI: Drugs Controller General of India The 2-DG anti-covid drug jointly developed by DRDO’s INMAS laboratory and Dr. Reddy’s Laboratories has finally been launched yesterday (Monday, 17th May, 2021). […]

Read More
  • BiotechToday
  • World

Clinical Chemistry Analyzer in Laboratory Setting

bioxone November 24, 2020November 24, 2020 1

Sagnik Nag, Amity University Kolkata On November 18, 2020, the Medica EasyRA benchtop clinical chemistry analyzer was distributed and serviced by Greensboro-based company, which provides healthcare officials and staff to keep a routine test on blood chemistries to include and check metabolic activity profiles, liver enzymes, proper kidney functioning glucose levels, and cardiovascular tests. These […]

Read More
  • India

FELUDA – the rapid test strip method to detect COVID-19

bioxone September 21, 2020September 21, 2020

-Ruchita Karmakar, Amity University Kolkata A research team led by Debojyoti Chakraborty and Souvik Maiti of CSIR and TATA group came up with a new test named FELUDA  to detect COVID-19. It’s a paper test strip that gives a precise result within 30 minutes; Approved for commercial launch by the Drugs Controller General of India. […]

Read More
  • Biotechnopedia

Asymptomatic patients of COVID-19: threat to the population?

bioxone September 18, 2020September 18, 2020

-Anwesha Chatterjee, Amity University Kolkata The novel coronavirus is spreading rapidly throughout the world. It is impossible to restrict the spread of the SARS-CoV-2.  A huge proportion of the population across the world got infected and showed the most common to mild to serious symptoms (fever, dry cough, respiratory problems, conjunctivitis, aches, pains, rashes, and many more) along with the high […]

Read More
  • India

Indian Covaxin – One Step closer to success

bioxone September 18, 2020September 18, 2020 2

–Thota Kanishka Rao, Amity University Kolkata Hyderabad-based Bharat Biotech in a joint effort with analysts from the ICMR’s National Institute of Virology, based in Pune has delivered the information from the creature preliminaries of its immunization competitor. It demonstrated that Covaxin had the option to produce ‘robust immune responses. The two-portion vaccination routine of Covaxin […]

Read More
  • BiotechToday
  • World

COVID UPDATE: Newly discovered tiny antibodies are completely defeating the menacing coronavirus

bioxone September 16, 2020September 16, 2020

-Binayak Das,Team bioXone A team of scientists has successfully isolated what they believe to be, as being the smallest biological molecule found till date, it being approximately one-tenth the size of an average antibody molecule. They have designed a therapeutic and pre-emptive drug called- Ab8 using it, which they propose will be able to not […]

Read More

Posts navigation

1 2 3

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy